Atlas FDA

DEXCOM CGM

FDA premarket approval P050012/S045 · decided 2012-08-17

Approval details

PMA number
P050012
Supplement
S045
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
DEXCOM CGM
Generic name
Sensor, glucose, invasive
Applicant
Dexcom, Inc.
Date received
2012-02-21
Decision date
2012-08-17
Days to decision
178 days
Decision code
APPR
Product code
MDS
Advisory committee
Clinical Chemistry
Expedited review
No
Location
San Diego, CA
Statement
APPROVAL FOR 1) THE ADDITION OF NEW COMPONENTS TO THE GLOBAL TRANSMITTER/GLOBAL RECEIVER SYSTEM ALLOWING COMMUNICATION AT 2.4 GHZ; 2) MINOR MODIFICATIONS TO THE APPLICATOR BAIL AND SAFETY CARD; AND 3) UPDATES TO THE OPTIONAL DATA MANAGER SOFTWARE THAT IS PROVIDED WITH THE SEVEN PLUS CGM SYSTEM. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME DEXCOM COLOR CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEM, AND IS A GLUCOSE-MONITORING DEVICE INDICATED FOR DETECTING AND TRACKING GLUCOSE TREN

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Stelo Glucose Biosensor System (K260935)Dexcom, Inc.2026-06-12
Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System (K261402)Dexcom, Inc.2026-06-08
Stelo Glucose Biosensor System (K261359)Dexcom, Inc.2026-05-21
Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253737)Dexcom, Inc.2026-02-03
Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System (K253710)Dexcom, Inc.2025-12-17
Dexcom Smart Basal (K252818)Dexcom, Inc.2025-11-18
Dexcom G7 15 Day Continuous Glucose Monitoring System (K243214)Dexcom, Inc.2025-04-09
Dexcom G7 Continuous Glucose Monitoring System (K240902)Dexcom, Inc.2024-04-23